Abnormal Urinary Loss of Vitamin C in Diabetes: Prevalence and Clinical Characteristics of a Vitamin C Renal Leak
Overview
Authors
Affiliations
Background: Diabetes is associated with low plasma vitamin C concentrations.
Objectives: We investigated the contribution of dysregulated vitamin C renal physiology, its prevalence, and associated clinical characteristics.
Methods: An essential prerequisite was determination of normal vitamin C renal threshold, the plasma concentration at which vitamin C first appears in urine. Using data from 17 healthy participants who underwent vitamin C depletion-repletion studies with a vitamin C dose range of 15-1250 mg daily, renal threshold was estimated using physiology-based pharmacokinetics modeling. Applying renal threshold 95% CIs, we estimated the minimal elimination threshold, the plasma concentration below which no vitamin C was expected in urine of healthy people. Renal leak was defined as abnormal presence of vitamin C in urine with plasma concentrations below the minimal elimination threshold. Criteria were tested in a cross-sectional cohort study of individuals with diabetes (82) and nondiabetic controls (80) using matched plasma and urine samples.
Results: Vitamin C renal thresholds in healthy men and women were [mean (SD)] 48.5 (5.2) µM and 58.3 (7.5) µM, respectively. Compared with nondiabetic controls, participants with diabetes had significantly higher prevalence of vitamin C renal leak (9% compared with 33%; OR: 5.07; 95% CI: 1.97, 14.83; P < 0.001) and 30% lower mean plasma vitamin C concentrations (53.1 µM compared with 40.9 µM, P < 0.001). Fasting plasma glucose, glycosylated hemoglobin A1c, BMI, micro/macrovascular complications, and protein/creatinine ratio were predictive of vitamin C renal leak.
Conclusions: Increased prevalence of vitamin C renal leak in diabetes is associated with reduced plasma vitamin C concentrations. Glycemic control, microvascular complications, obesity, and proteinuria are predictive of renal leak.
Paller C, Zahurak M, Mandl A, Metri N, Lalji A, Heath E Cancer Res Commun. 2024; 4(8):2174-2182.
PMID: 39076107 PMC: 11333993. DOI: 10.1158/2767-9764.CRC-24-0225.
Molecular Pharmacology of Vitamin C and Relevance to Health and Obesity-A Narrative Review.
Wilson R, Liang Y, Kaushal D, Carr A Int J Mol Sci. 2024; 25(14).
PMID: 39062764 PMC: 11276620. DOI: 10.3390/ijms25147523.
The evidence to date: implications of l-ascorbic acid in the pathophysiology of aging.
Sato A, Kondo Y, Ishigami A J Physiol Sci. 2024; 74(1):29.
PMID: 38730366 PMC: 11088021. DOI: 10.1186/s12576-024-00922-7.
A Systematized Review of the Relationship Between Obesity and Vitamin C Requirements.
Bird J, Feskens E, Melse-Boonstra A Curr Dev Nutr. 2024; 8(5):102152.
PMID: 38666038 PMC: 11039309. DOI: 10.1016/j.cdnut.2024.102152.
Vitamin C - a scoping review for Nordic Nutrition Recommendations 2023.
Lykkesfeldt J, Carr A Food Nutr Res. 2024; 67.
PMID: 38187788 PMC: 10770653. DOI: 10.29219/fnr.v67.10300.